Prevalence of clinical and ambulatory hypertension in a population of 65-year-olds: The PROOF study

Journal of Clinical Hypertension

Volumn 12, Issue 3, 2010, Pages 160-165

  Gosse, Philippe ^a   Dauphinot, Virginie ^b   Roche, Frederic ^b   Pichot, Vincent ^c   Celle, Sebastien ^c   Barthelemy, Jean Claude ^c  

^a HÔPITAL SAINT ANDRÉ   (France)

^b Hop Neurologique Pierre Wertheimer   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; EUROPE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAYNAUD PHENOMENON; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; AGED; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 77950198227     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00235.x     Document Type: Article

References (25)

1. Barthelemy JC, Pichot V, Dauphinot V. Autonomic nervous system activity and decline as prognostic indicators of cardiovascular and cerebrovascular events: the 'PROOF' Study. Study design and population sample. Associations with sleep-related breathing disorders: the 'SYNAPSE' Study. Neuroepidemiology 2007, 29:18-28.
2. Mancia G, De Backer G, Dominiczak A. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25(6):1105-1187.
3. Kearney PM, Whelton M, Reynolds K. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004, 22:11-19.
4. Kearney PM, Whelton M, Reynolds K. Global burden of hypertension: analysis of worrlwide data. Lancet 2005, 365:217-223.
5. Meisinger C, Heier M, Volzke H. Regional disparities of hypertension prevalence and management within Germany. J Hypertens 2006, 24:293-299.
6. Wolf-Maier K, Cooper RS, Banegas JR. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. JAMA 2003, 289:2363-2369.
7. Eguchi K, Pickering TG, Kario K. Why is blood pressure so hard to control in patients with type 2 diabetes? J Cardiometab Syndr 2007, 2:114-118.
8. Mancia G, Volpe R, Boros S. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 2004, 22:51-57.
9. Pickering TG, James GD, Boddie C. How common is white coat hypertension? JAMA 1988, 259:225-228.
10. Ohkubo T, Kikuya M, Metoki H. Prognosis of " masked" hypertension and " white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005, 46:508-515.
11. Wei TM, Lu LC, Ye XL. Difference in blood pressure between supine and sitting positions in diabetic and non-diabetic subjects. Med Sci Monit 2009, 15:CR123-CR127.
12. Lu LC, Wei TM, Li S. Differences in blood pressure readings between supine and sitting positions in hypertensive patients. Acta Cardiol 2008, 63:707-711.
13. Netea RT, Elving LD, Lutterman JA. Body position and blood pressure measurement in patients with diabetes mellitus. J Intern Med 2002, 251:393-399.
14. Netea RT, Smits P, Lenders JW. Does it matter whether blood pressure measurements are taken with subjects sitting or supine? J Hypertens 1998, 16:263-268.
15. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007, 30:479-488.
16. Eguchi K, Pickering TG, Hoshide S. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens 2008, 21:443-450.
17. Ohkubo T, Kikuya M, Asayama K. Incorporating self-blood pressure measurements at home in the guideline from the Ohasama study. Blood Press Monit 2007, 12:407-409.
18. Stergiou GS, Kalogeropoulos PG, Baibas NM. Prognostic value of home blood pressure measurement. Blood Press Monit 2007, 12:391-392.
19. Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens 2008, 26:1919-1927.
20. Parati G, Valentini M. Do we need out-of-office blood pressure in every patient? Curr Opin Cardiol 2007, 22:321-328.
21. Ommen ES, Lipkowitz MS. The role of ambulatory BP monitoring in clinical care. Geriatrics 2007, 62:11-14.
22. Myers MG, Godwin M. Automated measurement of blood pressure in routine clinical practice. J Clin Hypertens (Greenwich) 2007, 9:267-270.
23. Helvaci MR, Seyhanli M. What a high prevalence of white coat hypertension in society. Intern Med 2006, 45:671-674.
24. Hanon O. [Management of hypertension in the very elderly]. Presse Med 2006, 35:1047-1053.
25. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension 2006, 47:29-34.